Rezolute, Inc. (RZLT)
3.29
+0.01
(+0.30%)
USD |
NASDAQ |
Feb 20, 16:00
3.285
0.00 (0.00%)
After-Hours: 20:00
Rezolute SG&A Expense (Quarterly) : 9.873M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Pfizer Inc. | 4.162B |
| Geron Corp. | 39.00M |
| XOMA Royalty Corp. | 9.734M |
| CorMedix, Inc. | 36.64M |
| Sarepta Therapeutics, Inc. | 91.89M |